BRCA2 and breast cancer: To evaluate whether methylation of BRCA2 may decrease its inhibitory effects on the regulation of RAD51, expression of RAD51 and BRCA2 was analyzed in breast cancer samples (n = 873) with low-methylated BRCA2 (n = 436) or high-methylated BRCA2 (n = 437).